Optimizing Drug-Device Combination Manufacturing
This playbook explores key strategies for overcoming challenges in drug-device combination product development, ensuring quality, scalability, and successful market entry.…
The Latest Developments in Oncology Research
Explore oncology's recent research boom and where the industry is headed next. Drugmakers and, largely, the FDA argue that the…
Alnylam’s patisiran, the first ever FDA- and European Commission-approved RNAi therapeutic
Lipid nanoparticle structure On August 10, 2018, Alnylam Pharmaceuticals (Cambridge, MA) announced the first-ever FDA approval of an RNAi (RNA…
Cohort Management – Best Practices for Early Phase Oncology…
The Art and Science of Cohort Management Position your oncology research for success with evidence-based strategies for cohort optimization, safety…
Webinar: DIRmageddon? Not So Fast! Practical Strategies to Tackle the Changing DIR Landscape
The post Webinar: DIRmageddon? Not So Fast! Practical Strategies to Tackle the Changing DIR Landscape appeared first on Parata. Source…
6 Signs a Practice Is Your Fur-Ever Home
🐶 Before You Say Yes: 6 Signs a Practice Is Your Fur-Ever Home When you’re deep into interviews, pre-offer conversations,…